Atwood & Palmer’s Avanos Medical AVNS Stock Holding History

Atwood & Palmer’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,000	Closed	-$520K	–	442
2021 Q4	$520K	Hold	15,000	–	–	0.04%	110
2021 Q3	$468K	Hold	15,000	–	–	0.04%	112
2021 Q2	$546K	Hold	15,000	–	–	0.05%	101
2021 Q1	$656K	Hold	15,000	–	–	0.06%	91
2020 Q4	$688K	Hold	15,000	–	–	0.07%	87
2020 Q3	$498K	Hold	15,000	–	–	0.06%	87
2020 Q2	$441K	Hold	15,000	–	–	0.06%	87
2020 Q1	$404K	Hold	15,000	–	–	0.06%	88
2019 Q4	$506K	Hold	15,000	–	–	0.07%	85
2019 Q3	$562K	Hold	15,000	–	–	0.08%	83
2019 Q2	$654K	Sell	15,000 -7,726	-34%	-$330K	0.09%	79
2019 Q1	$970K	Hold	22,726	–	–	0.14%	66
2018 Q4	$1.02M	Buy	22,726 +1,330	+6%	+$69.7K	0.16%	65
2018 Q3	$1.47M	Buy	+21,396	New	+$1.38M	0.19%	59
2018 Q2	–	Sell	-4,881	Closed	-$225K	–	315
2018 Q1	$225K	Hold	4,881	–	–	0.03%	117
2017 Q4	$225K	Hold	4,881	–	–	0.03%	123
2017 Q3	$220K	Hold	4,881	–	–	0.03%	121
2017 Q2	$192K	Hold	4,881	–	–	0.03%	127
2017 Q1	$186K	Hold	4,881	–	–	0.03%	119
2016 Q4	$180K	Hold	4,881	–	–	0.03%	118
2016 Q3	$169K	Hold	4,881	–	–	0.03%	122
2016 Q2	$159K	Sell	4,881 -6	-0.1%	-$184	0.03%	128
2016 Q1	$140K	Sell	4,887 -485	-9%	-$12.9K	0.02%	128
2015 Q4	$179K	Hold	5,372	–	–	0.03%	133
2015 Q3	$153K	Sell	5,372 -65	-1%	-$2.27K	0.03%	132
2015 Q2	$220K	Hold	5,437	–	–	0.04%	124
2015 Q1	$268K	Sell	5,437 -23	-0.4%	-$1.06K	0.05%	110
2014 Q4	$249K	Buy	+5,460	New	+$215K	0.05%	108

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atwood & Palmer's AVNS Position: Q1 2022 in Review

Atwood & Palmer sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 15,000 shares — an estimated $520K sold.

Atwood & Palmer first reported a position in AVNS in Q4 2014 and held it in 28 quarters. The position peaked at $1.47M in Q3 2018. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

Atwood & Palmer reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
Atwood & Palmer sold 15,000 Avanos Medical shares in Q1 2022, an estimated $520K.
Atwood & Palmer first reported a position in Avanos Medical in Q4 2014 and held it in 28 quarters.
Atwood & Palmer's Avanos Medical position peaked at $1.47M in Q3 2018.
299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Atwood & Palmer's 13F filing for Q1 2022, filed 29 Apr 2022.